Anzeige
Meldung des Tages: Der Vorteil des Meeresbodens: Wie Tiefsee-Knollen den landbasierten Bergbau übertreffen könnten

Xtant Medical Holdings News

Aktie
WKN:  A2JDJS ISIN:  US98420P3082 US-Symbol:  XTNT Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
0,4816 $
-0,0034 $
-0,70%
0,40939 € 17.04.26
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
26,34%
KGV
-3,69
Index-Zuordnung
-

Xtant Medical Holdings News

13.04.26 - PR Newswire
Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product
Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product PR Newswire
09.04.26 - PR Newswire
Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial
Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial PR Newswire
31.03.26 - PR Newswire
Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results
Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results PR Newswire
25.03.26 - PR Newswire
Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026
Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026 PR Newswire
02.03.26 - PR Newswire
Xtant Medical Finalizes Companion Spine Transactions
Xtant Medical Finalizes Companion Spine Transactions PR Newswire
25.02.26 - PR Newswire
Xtant Medical to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference
Xtant Medical to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference PR Newswire
11.12.25 - PR Newswire
Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft
Xtant Medical Announces Commercial Launch of its Next-​Generation nanOss Strata™ Synthetic Bone Graft PR Newswire
01.12.25 - PR Newswire
Xtant Medical Completes Sale of its Coflex® Assets and Paradigm OUS Businesses to Companion Spine
Xtant Medical Completes Sale of its Coflex® Assets and Paradigm OUS Businesses to Companion Spine PR Newswire
10.11.25 - PR Newswire
Xtant Medical Reports Third Quarter 2025 Financial Results
Xtant Medical Reports Third Quarter 2025 Financial Results PR Newswire
05.11.25 - PR Newswire
Xtant Medical Announces Commercial Launch of CollagenX™
Xtant Medical Announces Commercial Launch of CollagenX™ PR Newswire
04.11.25 - PR Newswire
Xtant Medical to Announce Third Quarter 2025 Financial Results on November 11, 2025
Xtant Medical to Announce Third Quarter 2025 Financial Results on November 11, 2025 PR Newswire
04.09.25 - PR Newswire
Xtant Medical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Xtant Medical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference PR Newswire
12.08.25 - PR Newswire
Xtant Medical Reports Second Quarter 2025 Financial Results
Xtant Medical Reports Second Quarter 2025 Financial Results PR Newswire
06.08.25 - PR Newswire
Xtant Medical to Attend the CG 45th Annual Growth Conference
Xtant Medical to Attend the CG 45th Annual Growth Conference PR Newswire
05.08.25 - PR Newswire
Xtant Medical to Announce Second Quarter 2025 Financial Results on August 12, 2025
Xtant Medical to Announce Second Quarter 2025 Financial Results on August 12, 2025 PR Newswire
08.07.25 - PR Newswire
Xtant Medical Announces Definitive Agreements for the Sale of its Coflex® and CoFix® Spinal Implants and All OUS Businesses to Companion Spine
Xtant Medical Announces Definitive Agreements for the Sale of its Coflex® and CoFix® Spinal Implants and All OUS Businesses to Companion Spine PR Newswire
28.05.25 - PR Newswire
Xtant Medical Announces the Launch of OsteoFactor Pro™
Xtant Medical Announces the Launch of OsteoFactor Pro™ PR Newswire
12.05.25 - PR Newswire
Xtant Medical Reports First Quarter 2025 Financial Results
Xtant Medical Reports First Quarter 2025 Financial Results PR Newswire
06.05.25 - PR Newswire
Xtant Medical to Issue First Quarter 2025 Financial Results on May 12, 2025
Xtant Medical to Issue First Quarter 2025 Financial Results on May 12, 2025 PR Newswire
23.04.25 - PR Newswire
Xtant Medical Launches Trivium™ Advanced Bone Graft for Superior Performance
Xtant Medical Launches Trivium™ Advanced Bone Graft for Superior Performance PR Newswire

Newssuche

Videos

newspaper
16.04.26 +2,80%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »